|
TeraView’s goal is to establish
a high growth products and solutions-based business,
and strengthen its position as the dominant supplier
of Terahertz based technology that can be applied to
targeted markets.
The original development of semiconductor
source and detector technology used in terahertz technology
was
carried out by Toshiba Research Europe Ltd in 1993-2001.
Toshiba spun out this terahertz activity into TeraView
Limited in April 2001 along with a consortium of
UK-based venture capital investors. Toshiba retains
a minority
stake in TeraView, which holds all the original intellectual
property, equipment, and personnel.
Since 2001, TeraView has been responsible
for the rapid commercialization of terahertz technology
past the
proof-of-principle stage. The management and commercial
teams have been built up, target markets have been
identified and commercial focus on these established,
applications and technology have been developed
and our patent portfolio grown considerably.
The Company
is currently focused upon establishing its technology
in the pharmaceutical and analytical
instrumentation market, with other select markets
and revenue opportunities explored through
partnerships with global players and government agencies
active
in those markets.
TeraView has a portfolio of investors
who have continued to strongly supported the Company
over
the past several
years, and bring both great breadth and depth
of experience with spin-off technology companies:
- Amadeus Capital Partners
- TTPVentures
- Cambridge Gateway
- Quester
- University of Cambridge
- Trinity College, Cambridge
TeraView also has three corporate
investors who enhance the global nature of the company
and give it additional access to international markets:
- KLA Tencor, US
- Coherent, US
- Toshiba Research Europe
|
